NCT00291538View on ClinicalTrials.gov

Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

October 31, 2008

Conditions
Multiple Myeloma
Interventions
DRUG

bortezomib

Trial Locations (3)

44093

Nantes UH, Nantes

54000

Nancy UH, Nancy

59000

Lille UH, Lille

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT00291538 - Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter